IIT RESEARCH INSTITUTE

CHICAGO, IL, 60616

Prime contracting experience

35 records from government sources. Past participation is not evidence of current teaming interest.

Role	Agency	Description	Vehicle	Obligated	Action date	Period
Prime	Department of Health and Human Services National Institutes of Health	IGF::OT::IGF NEXT PRECLINICAL TOXICOLOGY&PHARMACOLOGY OF DRUGS DEVELOPED FOR CANCER PATIENTS, TO#3, EXPLORATORY STUDIES OF CCR4 CART CELLS HHSN26100003USAspending	HHSN261201600015IUSAspending	$626,266	Sep 28, 2026	Sep 6, 2017 – Sep 30, 2022
Prime	Department of Health and Human Services National Institutes of Health	FIRST-IN-CLASS SMALL MOLECULE CANDIDATE NCGC72 (CD206 AGONIST) FOR IMMUNOLOGICALLY COLD SOLID ORGAN CANCERS 75N95024F00002USAspending	75N95024D00020USAspending	$547,006	Aug 11, 2026	Sep 18, 2024 – Dec 31, 2025
Prime	Department of Health and Human Services National Institutes of Health	PRECLINICAL TOXICOLOGY OF LARGE MOLECULE DRUGS DEVELOPED FOR CANCER AND OTHER INDICATIONS 75N91022C00010USAspending	—	$3,452,984	Jul 29, 2026	Apr 1, 2022 – Mar 31, 2027
Prime	Department of Health and Human Services National Institutes of Health	NON-CLINICAL SAFETY ASSESSMENT OF DRINABANT, A CANNABINOID RECEPTOR (CB-1) ANTAGONIST, FOR ACUTE CANNABINOID OVERDOSE (ACO). POP: 09/25/2020 TO 03/24/2021. 75N95020F00003USAspending	HHSN271201700016IUSAspending	$751,371	Jul 14, 2026	Sep 25, 2020 – Dec 31, 2024
Prime	Department of Health and Human Services National Institutes of Health	TOXICOLOGY STUDIES IN RATS AND DOGS ADMINISTERED AIT-102 75N91024F00003USAspending	75N91022D00016USAspending	$627,793	Jun 30, 2026	Sep 16, 2024 – Oct 31, 2026
Prime	Department of Health and Human Services National Institutes of Health	TASK ORDER AWARD- SSL GLP AND NON-GLP TOXICOLOGY STUDIES 75N98026F00001USAspending	75N95021D00026USAspending	$3,391,980	Jun 26, 2026	Jun 25, 2026 – Dec 25, 2027
Prime	Department of Health and Human Services National Institutes of Health	IGF::OT::IGF LFA-9 (MPGES-1/5-LOX INHIBITOR): PRECLINICAL STUDIES TO SUPPORT A CLINICAL TRIAL, POP 9/17/18-9/16/2020 (UP TO 9/17/2021 IF ALL OPTIONAL TASKS EXERCISED) 75N91018F00005USAspending	HHSN261201500024IUSAspending	$1,984,676	Dec 2, 2025	Sep 17, 2018 – Jul 25, 2025
Prime	Department of Health and Human Services National Institutes of Health	TASK ORDER: TOPICAL RESATORVID FOR NONMELANOMA SKIN CANCER PREVENTION PERIOD OF PERFORMANCE: 09/21/2020 - 03/20/2022 75N91020F00001USAspending	75N91019D00013USAspending	$1,161,990	Nov 18, 2025	Sep 21, 2020 – Jan 31, 2026
Prime	Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	IGF::OT::IGF 75A50118F33002USAspending	HHSO100201700014IUSAspending	$2,437,669	Sep 29, 2025	Sep 24, 2018 – Sep 30, 2021
Prime	Department of Health and Human Services National Institutes of Health	PTTP TASK ORDER - IITRI - MS RODENT AND NON-RODENT MTD-DRF STUDIES 75N95025F00001USAspending	75N95021D00026USAspending	$401,373	Sep 25, 2025	Sep 26, 2025 – Sep 25, 2026
Prime	Department of Health and Human Services National Institutes of Health	PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF PROSTATE CANCER 75N91020F00001USAspending	75N91019D00012USAspending	$1,736,011	Sep 16, 2025	Sep 8, 2020 – May 7, 2025
Prime	Department of Health and Human Services National Institutes of Health	TOXICOLOGY STUDIES IN MICE AND DOGS ADMINISTERED MTX-531 75N91024F00002USAspending	75N91022D00016USAspending	$1,790,042	May 8, 2025	Jun 12, 2024 – Jun 11, 2025
Prime	Department of Health and Human Services National Institutes of Health	BASE TITLE: PREVENT PRECLINICAL PHARMACOLOGY AND TOXICOLOGY TASK ORDER TITLE: NICOTINE REDUCTION THERAPY USING THE HUMAN MONOCLONAL ANTIBODY ATI-1013 75N91023F00001USAspending	75N91019D00013USAspending	$656,577	May 6, 2025	Sep 22, 2023 – Apr 25, 2025
Prime	Department of Health and Human Services National Institutes of Health	NON-CLINICAL SAFETY ASSESSMENT OF COVALENT BI-TOX TO SUPPORT NEUROPATHIC PAIN INDICATION 75N95022F00001USAspending	HHSN271201700016IUSAspending	$765,995	Apr 29, 2025	Sep 23, 2022 – Apr 29, 2025
Prime	Department of Health and Human Services National Institutes of Health	NON-CLINICAL SAFETY OF PTH-1A, INVERSE AGONIST, TO SUPPORT JANSEN METAPHYSEAL CHONDRODYSPLASIA (JMC) DISEASE. POP: 09/16/2020 TO 03/15/2020. 75N95020F00001USAspending	HHSN271201700016IUSAspending	$3,053,804	Jan 16, 2025	Sep 16, 2020 – Sep 30, 2024
Prime	Department of Health and Human Services National Institutes of Health	TASK ORDER TITLE: NON-CLINICAL SAFETY OF MITRAGYNINE TO SUPPORT ITS FUTURE ORAL THERAPY FOR ANALGESIA INDICATION. POP: 09/17/2020 TO 03/16/2022. 75N95020F00002USAspending	HHSN271201700016IUSAspending	$2,373,515	Dec 19, 2024	Sep 17, 2020 – Oct 31, 2025
Prime	Department of Health and Human Services National Institutes of Health	IITRI - PTTP DRF BPN STUDY - TO3 75N95024F00002USAspending	75N95021D00026USAspending	$438,148	Nov 5, 2024	Mar 1, 2024 – Feb 28, 2025
Prime	Department of Health and Human Services National Institutes of Health	EVALUATION OF AFPEP FOR THE PREVENTION OF BREAST CANCER 75N91021F00001USAspending	75N91019D00012USAspending	$532,562	Jul 9, 2024	Sep 6, 2021 – Jul 31, 2024
Prime	Department of Health and Human Services National Institutes of Health	NON-CLINICAL SAFETY ASSESSMENT OF ACOZIBOROLE (SCYX-7158) TO SUPPORT HUMAN AFRICAN TRYPANOSOMIASIS (HAT OR "SLEEPING SICKNESS"). POP: 09/01/2019 TO 08/31/2020. 75N95019F00091USAspending	HHSN271201700016IUSAspending	$1,156,165	Apr 10, 2024	Sep 1, 2019 – Aug 31, 2021
Prime	Department of Health and Human Services National Institutes of Health	GLP 28 DAY TOXICITY STUDY OF ACT-1 WHEN APPLIED TOPICALLY TO EYES TWICE DAILY FOR 28 DAYS IN DOGS WITH A 14 DAY RECOVERY PERIOD. POP: 09/01/2019 TO 02/29/2020. 75N95019F00090USAspending	HHSN271201700016IUSAspending	$547,622	Mar 5, 2024	Sep 1, 2019 – Oct 30, 2020
Prime	Department of Defense Department of the Army	IGF::OT::IGF SUSTAINMENT AND MAINTENANCE OF BIOSURETY W911QY17C0040USAspending	—	$1,615,711	Sep 25, 2023	Mar 1, 2017 – Feb 28, 2018
Prime	Department of Health and Human Services National Institutes of Health	IIT RESEARCH INSTITUTE:1107221 [18-004523] 75N95018F00002USAspending	HHSN271201700016IUSAspending	$271,489	Jun 22, 2023	Jun 1, 2018 – Aug 30, 2019
Prime	Department of Health and Human Services National Institutes of Health	NON-CLINICAL SAFETY ASSESSMENT OF BPN14770 TO SUPPORT PEDIATRIC POPULATION WITH FRAGILE X SYNDROME 75N95018F00005USAspending	HHSN271201700016IUSAspending	$789,821	Jun 22, 2023	Sep 7, 2018 – Apr 30, 2020
Prime	Department of Health and Human Services National Institutes of Health	IIT RESEARCH INSTITUTE:1107221 75N95018F00004USAspending	HHSN271201700016IUSAspending	$913,178	Jun 22, 2023	Aug 31, 2018 – Jul 31, 2019
Prime	Department of Health and Human Services National Institutes of Health	COVID-19 RELATED STUDY INVOLVING DOGS 75N91020F00002USAspending	75N91019D00013USAspending	$597,893	Aug 24, 2022	Sep 16, 2020 – Mar 15, 2021
Prime	Department of Defense Department of the Army	TECHNLOLOGY TRANSFER ASSAYS W911QY21C0014USAspending	—	$646,074	Jul 27, 2022	Nov 30, 2020 – Nov 29, 2021
Prime	Department of Health and Human Services National Institutes of Health	SUPPORT FOR THE PRECLINICAL DEVELOPMENT OF EIF4A INHIBITORS ROCAGLAMIDE AND DIDESMETHYLROCAGLAMIDE. (TOXICIOLOGY SERVICES TO SUPPORT PRECLINICAL DRUG DEVELOPMENT) POP 09/23/2020-09/22/2021. 75N91020F00001USAspending	HHSN261201600015IUSAspending	$588,615	Jul 26, 2022	Sep 23, 2020 – Aug 31, 2022
Prime	Department of Health and Human Services National Institutes of Health	PRECLINICAL MICROBIOLOGICAL, SAFETY, TOXICOLOGY, AND PHARMACOKINETIC SERVICES 75N93022F00001USAspending	75N93018D00005USAspending	$1,883,524	Jun 30, 2022	Dec 10, 2021 – Jul 1, 2022
Prime	Department of Health and Human Services National Institutes of Health	IGF::OT::IGF SUPPORT FOR ENDOXIFEN GEL CLINICAL DEVELOPMENT HHSN26100002USAspending	HHSN261201500024IUSAspending	$1,181,806	May 2, 2022	Sep 19, 2016 – Dec 18, 2020
Prime	Department of Health and Human Services Food and Drug Administration	IGF::OT::IGF INHALATION STUDY OF THE IN VIVO TOXICITY OF ESSENTIAL OILS HHSF22301001TUSAspending	HHSF223201510033IUSAspending	$1,574,100	May 1, 2022	Sep 14, 2017 – Sep 14, 2022
Prime	Department of Health and Human Services National Institutes of Health	PRECLINICAL EFFICACY EVALUATION OF THE LIPID-BASED SMEDDS FORMULATION OF DIM, BR-9001, TO AWARD 3 75N91018F00003USAspending	HHSN261201500042IUSAspending	$970,988	Apr 22, 2022	Aug 8, 2018 – Feb 7, 2022
Prime	Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	IGF::OT::IGF ASPR-16-05523 -- TASK ORDER TO IITRI UNDER RTOR BIO-0023 FOR PRODUCTION OF ZIKA VIRUS REGENTS AND ASSAYS HHSO10033001TUSAspending	HHSO100201100013IUSAspending	$1,162,951	Mar 21, 2022	Sep 28, 2016 – Apr 16, 2018
Prime	Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response	IGF::OT::IGF 75A50118F33001USAspending	HHSO100201700014IUSAspending	$2,561,491	Mar 1, 2022	Sep 25, 2018 – Sep 30, 2022
Prime	Department of Health and Human Services National Institutes of Health	IGF::OT::IGF HHSN2612015000241 PERIOD OF PERFORMANCE: 9/15/16 TO 10/14/2018 PRECLINICAL EVALUATION OF A NEW LIPID-BASED SMEDDS HHSN26100003USAspending	HHSN261201500024IUSAspending	$321,111	Feb 17, 2022	Sep 15, 2016 – Jan 14, 2019
Prime	Department of Health and Human Services National Institutes of Health	IGF::OT::IGF TASK ORDER AWARD FOR "NON-CLINICAL SAFETY ASSESSMENT OF SPIF TO SUPPORT CHRONIC GVHD INDICATION" TO IIT RESEARCH INSTITUTE HHSN27100001USAspending	HHSN271201700016IUSAspending	$1,569,964	Jan 18, 2022	Sep 14, 2017 – Nov 30, 2020

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Subcontracting experience

4 records from government sources. Past participation is not evidence of current teaming interest.

Role	Agency	Description	Vehicle	Obligated	Action date	Period
Subcontractor	Department of Health and Human Services	RRV-SC M7 SUBC 20X114QF11 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541715 Parent award performance state: MD Parent award description: VRC RAPID MANUFACTURING RESPONSE: NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT View parent award on USAspending	75N91019D00024USAspending	$932,315	Jan 12, 2026	— – —
Subcontractor	Department of Defense	SAMPLE ANALYSIS 0000900252 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541712 Parent award performance state: OH Parent award description: PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM. View parent award on USAspending	GS00Q14OADU402USAspending	$32,000	Aug 14, 2024	— – —
Subcontractor	Department of Defense	SERVICES S5001909 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541715 Parent award performance state: MD Parent award description: STABILITY TESTING View parent award on USAspending	—	$2,152,961	Jun 5, 2024	— – —
Subcontractor	Department of Health and Human Services	REPEAT DOES TOXICITY STUDY OF MULTIVALENT ZIKA AND YELLOW FEVER VACCINE IN RABBITS (GLP). THE OBJECTIVE OF THIS STUDY ARE TO DETERMINE THE POTENTIAL TOXICITY OF A MULITVALENT ZIKA/YELLOW FEVER VACCINE IN NEW ZEALNAD WHITE RABBITS WHEN GIVEN AS FOUR DOSES TWO WEEKS APART VIA INTRAMUSCULAR (IM) INJECTION, AND TO EVALUATE RECOVER 4-WEEKS POST-LAST STUDY INJECTION. 75N93019C00059-IITRI-NV1190-OP2 Parent award context Parent award agency: Department of Health and Human Services · National Institutes of Health Parent award NAICS: 541714 Parent award performance state: WA Parent award description: TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 View parent award on USAspending	—	$467,558	Jun 30, 2023	— – —

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Agencies supported

Department of Health and Human ServicesGov-sourced
Department of DefenseGov-sourced

Is this your company?

Claim this profile for free to add your capabilities, teaming interests, capability statement link and employee count, and to report certifications for verification.

FedSub reviews every claim before granting access. Government-sourced data stays as published; your additions are labeled company-reported.

Claim this profile (free)

Identifiers

UEI: DGBUFQYMKWB5
CAGE: 03889
Website: http://www.iitri.org/

NAICS codes

541714Research and Development in Biotechnology (except Nanobiotechnology)(definition)
541715Research and Development in the Physical, Engineering, and Life SciencesPrimary(definition)
541711NAICS 541711(definition)
541712NAICS 541712(definition)
541690Other Scientific and Technical Consulting Services(definition)
325414Biological Product (except Diagnostic) Manufacturing(definition)
541380Testing Laboratories and Services(definition)

Data sources

USAspending.gov
ID recipient:DGBUFQYMKWB5 · fetched Oct 26, 2026 · source
SAM.gov monthly extract
ID DGBUFQYMKWB5 · fetched Oct 25, 2026 · source

Last synced Oct 26, 2026 · profile updated Oct 26, 2026

Find similar contractors

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.